India set to carry out phase 3 clinical trials for vaccine against dengue

Pharmaceutical companies and vaccine makers who have developed potential vaccine candidates against dengue and have successfully completed phase 1 and 2 clinical trials can submit their expressions of interest (EoI) to ICMR by 11 March

from mint - Science https://ift.tt/8dVh3p2
https://ift.tt/RCUMW1t